Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel Mechanism Controlling NFAT-Mediated Vascular Inflammation and Permeability.

IF 7.4 1区 医学 Q1 HEMATOLOGY
Ramoji Kosuru, Olivier Romito, Guru Prasad Sharma, Francesca Ferraresso, Behshid Ghadrdoost Nakhchi, Kai Yang, Tadanori Mammoto, Akiko Mammoto, Christian J Kastrup, David X Zhang, Paul H Goldspink, Mohamed Trebak, Magdalena Chrzanowska
{"title":"Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel Mechanism Controlling NFAT-Mediated Vascular Inflammation and Permeability.","authors":"Ramoji Kosuru, Olivier Romito, Guru Prasad Sharma, Francesca Ferraresso, Behshid Ghadrdoost Nakhchi, Kai Yang, Tadanori Mammoto, Akiko Mammoto, Christian J Kastrup, David X Zhang, Paul H Goldspink, Mohamed Trebak, Magdalena Chrzanowska","doi":"10.1161/ATVBAHA.124.321458","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Store-operated calcium entry mediated by STIM (stromal interaction molecule)-1-Orai1 (calcium release-activated calcium modulator 1) is essential in endothelial cell (EC) functions, affecting signaling, NFAT (nuclear factor for activated T cells)-induced transcription, and metabolic programs. While the small GTPase Rap1 (Ras-proximate-1) isoforms, including the predominant Rap1B, are known for their role in cadherin-mediated adhesion, EC deletion of Rap1A after birth uniquely disrupts lung endothelial barrier function. Here, we elucidate the specific mechanisms by which Rap1A modulates lung vascular integrity and inflammation.</p><p><strong>Methods: </strong>The role of EC Rap1A in lung inflammation and permeability was examined using in vitro and in vivo approaches.</p><p><strong>Results: </strong>We explored Ca<sup>2+</sup> signaling in human ECs following siRNA-mediated knockdown of Rap1A or Rap1B. Rap1A knockdown, unlike Rap1B, significantly increased store-operated calcium entry in response to a GPCR (G-protein-coupled receptor) agonist, ATP (500 µmol/L), or thapsigargin (250 nmol/L). This enhancement was attenuated by Orai1 channel blockers 10 μmol/L BTP2 (N-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide), 10 μmol/L GSK-7975A, and 5 μmol/L Gd<sup>3+</sup>. Whole-cell patch clamp measurements revealed enhanced Ca<sup>2+</sup> release-activated Ca<sup>2+</sup> current density in siRap1A ECs. Rap1A depletion in ECs led to increased NFAT1 nuclear translocation and activity and elevated levels of proinflammatory cytokines (CXCL1 [C-X-C motif chemokine ligand 1], CXCL11 [C-X-C motif chemokine 11], CCL5 [chemokine (C-C motif) ligand 5], and IL-6 [interleukin-6]). Notably, reducing Orai1 expression in siRap1A ECs normalized store-operated calcium entry, NFAT activity, and endothelial hyperpermeability in vitro. EC-specific Rap1A knockout (Rap1A<sup>iΔEC</sup>) mice displayed an inflammatory lung phenotype with increased lung permeability and inflammation markers, along with higher Orai1 expression. Delivery of siRNA against Orai1 to lung endothelium using lipid nanoparticles effectively normalized Orai1 levels in lung ECs, consequently reducing hyperpermeability and inflammation in Rap1A<sup>iΔEC</sup> mice.</p><p><strong>Conclusions: </strong>Our findings uncover a novel role of Rap1A in regulating Orai1-mediated Ca<sup>2+</sup> entry and expression, crucial for NFAT-mediated transcription and endothelial inflammation. This study distinguishes the unique function of Rap1A from that of the predominant Rap1B isoform and highlights the importance of normalizing Orai1 expression in maintaining lung vascular integrity and modulating endothelial functions.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":"2271-2287"},"PeriodicalIF":7.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495542/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.124.321458","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Store-operated calcium entry mediated by STIM (stromal interaction molecule)-1-Orai1 (calcium release-activated calcium modulator 1) is essential in endothelial cell (EC) functions, affecting signaling, NFAT (nuclear factor for activated T cells)-induced transcription, and metabolic programs. While the small GTPase Rap1 (Ras-proximate-1) isoforms, including the predominant Rap1B, are known for their role in cadherin-mediated adhesion, EC deletion of Rap1A after birth uniquely disrupts lung endothelial barrier function. Here, we elucidate the specific mechanisms by which Rap1A modulates lung vascular integrity and inflammation.

Methods: The role of EC Rap1A in lung inflammation and permeability was examined using in vitro and in vivo approaches.

Results: We explored Ca2+ signaling in human ECs following siRNA-mediated knockdown of Rap1A or Rap1B. Rap1A knockdown, unlike Rap1B, significantly increased store-operated calcium entry in response to a GPCR (G-protein-coupled receptor) agonist, ATP (500 µmol/L), or thapsigargin (250 nmol/L). This enhancement was attenuated by Orai1 channel blockers 10 μmol/L BTP2 (N-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide), 10 μmol/L GSK-7975A, and 5 μmol/L Gd3+. Whole-cell patch clamp measurements revealed enhanced Ca2+ release-activated Ca2+ current density in siRap1A ECs. Rap1A depletion in ECs led to increased NFAT1 nuclear translocation and activity and elevated levels of proinflammatory cytokines (CXCL1 [C-X-C motif chemokine ligand 1], CXCL11 [C-X-C motif chemokine 11], CCL5 [chemokine (C-C motif) ligand 5], and IL-6 [interleukin-6]). Notably, reducing Orai1 expression in siRap1A ECs normalized store-operated calcium entry, NFAT activity, and endothelial hyperpermeability in vitro. EC-specific Rap1A knockout (Rap1AiΔEC) mice displayed an inflammatory lung phenotype with increased lung permeability and inflammation markers, along with higher Orai1 expression. Delivery of siRNA against Orai1 to lung endothelium using lipid nanoparticles effectively normalized Orai1 levels in lung ECs, consequently reducing hyperpermeability and inflammation in Rap1AiΔEC mice.

Conclusions: Our findings uncover a novel role of Rap1A in regulating Orai1-mediated Ca2+ entry and expression, crucial for NFAT-mediated transcription and endothelial inflammation. This study distinguishes the unique function of Rap1A from that of the predominant Rap1B isoform and highlights the importance of normalizing Orai1 expression in maintaining lung vascular integrity and modulating endothelial functions.

Rap1A 调节肺内皮细胞中的钙输入:一种控制 NFAT 介导的血管炎症和渗透性的新机制
背景:STIM(基质相互作用分子)-1-Orai1介导的贮存操作钙离子进入对内皮细胞(EC)的功能至关重要,会影响信号传导、NFAT(活化T细胞核因子)诱导的转录和代谢程序。虽然小 GTPase Rap1 异构体(包括占主导地位的 Rap1B)因其在粘附素介导的粘附中的作用而闻名,但出生后内皮细胞缺失 Rap1A 会独特地破坏肺内皮屏障功能。在此,我们阐明了 Rap1A 调节肺血管完整性和炎症的具体机制:方法:采用体外和体内方法研究了肺内皮细胞 Rap1A 在肺部炎症和通透性中的作用:结果:我们研究了 siRNA 介导的 Rap1A 或 Rap1B 敲除后人类 EC 中的 Ca2+ 信号转导。与 Rap1B 不同的是,Rap1A 基因敲除能显著增加钙离子在 GPCR(G 蛋白偶联受体)激动剂、ATP(500 µmol/L)或巯基乙酸(250 nmol/L)作用下的储存操作钙离子输入。Orai1 通道阻断剂 10 μmol/L BTP2、10 μmol/L GSK-7975A 和 5 μmol/L Gd3+ 可减弱这种增强作用。全细胞膜片钳测量显示,siRap1A ECs 中 Ca2+ 释放激活的 Ca2+ 电流密度增强。EC 中 Rap1A 的缺失导致 NFAT1 核转位和活性增加,促炎细胞因子(CXCL1、CXCL11、CCL5 [趋化因子(C-C 矩阵)配体 5] 和 IL-6 [白细胞介素-6])水平升高。值得注意的是,减少 siRap1A EC 中 Orai1 的表达可使体外贮存操作钙离子进入、NFAT 活性和内皮高渗透性恢复正常。Rap1A特异性基因敲除(Rap1AiΔEC)小鼠表现出肺部炎症表型,肺通透性和炎症标志物增加,同时Orai1表达增加。利用脂质纳米颗粒将针对Orai1的siRNA递送到肺内皮细胞,有效地使肺内皮细胞中的Orai1水平恢复正常,从而降低了Rap1AiΔEC小鼠的高渗透性和炎症:我们的研究结果揭示了 Rap1A 在调节 Orai1 介导的 Ca2+ 进入和表达方面的新作用,而 Orai1 的进入和表达对 NFAT 介导的转录和内皮炎症至关重要。这项研究将 Rap1A 的独特功能与占主导地位的 Rap1B 异构体的功能区分开来,并强调了使 Orai1 表达正常化对维持肺血管完整性和调节内皮功能的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信